From: Factors associated with receipt of adjuvant chemotherapy among married women with breast cancer
Variable | ORa | 95% CIa | Adjusted Pa |
---|---|---|---|
Age at diagnosis (years) | |||
<50 | Referent | ||
50 to 69 | 0.690 | 0.386 to 1.234 | 0.211 |
≥70 | 0.303 | 0.143 to 0.643 | 0.002 |
Comorbidities | |||
None | Referent | ||
One or more | 1.090 | 0.810 to 1.467 | 0.568 |
Menopausal status | |||
Premenopause | Referent | ||
Menopause | 1.374 | 0.778 to 2.428 | 0.274 |
Residential status | |||
Rural | Referent | ||
Urban | 1.398 | 1.058 to 1.846 | 0.018 |
Tumor size | |||
≤2 | Referent | ||
>2 | 0.799 | 0.510 to 1.150 | 0.198 |
Lymph node metastasis | |||
Negative | Referent | ||
Positive | 1.383 | 1.057 to 1.809 | 0.018 |
Distant metastasis | |||
Negative | Referent | ||
Positive | 1.908 | 0.191 to 19.015 | 0.582 |
Hormone receptor statusa | |||
ER- and PR- | Referent | ||
ER + and/or PR+ | 1.425 | 0.981 to 2.070 | 0.063 |